Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
Background: It has been proposed that Trp (620) allotype of protein tyrosine phosphatases number 22 (PTPN22) gene can intensify the susceptibility to rheumatoid arthritis (RA) and other autoimmune diseases. Thus, in this study, the prevalence of this polymorphism has been surveyed among RA patients...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Advanced Biomedical Research |
Subjects: | |
Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=218;epage=218;aulast=Salesi |
id |
doaj-3bdec13770c84cbaa27d176b44cfa469 |
---|---|
record_format |
Article |
spelling |
doaj-3bdec13770c84cbaa27d176b44cfa4692020-11-24T22:48:07ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752277-91752014-01-013121821810.4103/2277-9175.143294Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patientsMansour SalesiGolshan Taghipour BoroujeniMansoor SalehiHadi KarimzadehBackground: It has been proposed that Trp (620) allotype of protein tyrosine phosphatases number 22 (PTPN22) gene can intensify the susceptibility to rheumatoid arthritis (RA) and other autoimmune diseases. Thus, in this study, the prevalence of this polymorphism has been surveyed among RA patients compared with healthy persons. The samples were selected from Isfahan province (one of the most populated area of Iran). Materials and Methods: In this study, 100 patients (case group) and 100 healthy persons (control group) were participated voluntarily. The case group was selected from people who had referred to the rheumatology clinic of AlZahra University Hospital to follow-up their treatment and change their drugs dosage. The control group members, who were living in Isfahan province, mutually had similar age with patients. On a total, 22% of the case group was male and 75% of the control group was female. DNA was extracted from the blood sample of all cases and controls and the PTPN22 single nucleotide polymorphism (SNP) C1858> T gene polymorphism were studied using the polymerase chain reaction-restriction fragment length polymorphism method. Results: PTPN22 SNP C1858> T gene polymorphism was observed in 11 persons (11%) of the case group and 8 persons (8%) of the control group. Conclusion: The results show that the difference was not statistically significant in Isfahan RA population (P = 0.47; OR = 1.42; 95% CI 0.55-3.69). Although, another study on Iranian population had shown that this polymorphism confers susceptibility to RA.http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=218;epage=218;aulast=SalesiIsfahanpolymorphismprotein tyrosine phosphates number 22rheumatoid arthritis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mansour Salesi Golshan Taghipour Boroujeni Mansoor Salehi Hadi Karimzadeh |
spellingShingle |
Mansour Salesi Golshan Taghipour Boroujeni Mansoor Salehi Hadi Karimzadeh Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients Advanced Biomedical Research Isfahan polymorphism protein tyrosine phosphates number 22 rheumatoid arthritis |
author_facet |
Mansour Salesi Golshan Taghipour Boroujeni Mansoor Salehi Hadi Karimzadeh |
author_sort |
Mansour Salesi |
title |
Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients |
title_short |
Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients |
title_full |
Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients |
title_fullStr |
Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients |
title_full_unstemmed |
Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients |
title_sort |
assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: a study on iranian patients |
publisher |
Wolters Kluwer Medknow Publications |
series |
Advanced Biomedical Research |
issn |
2277-9175 2277-9175 |
publishDate |
2014-01-01 |
description |
Background: It has been proposed that Trp (620) allotype of protein tyrosine phosphatases number 22 (PTPN22) gene can intensify the susceptibility to rheumatoid arthritis (RA) and other autoimmune diseases. Thus, in this study, the prevalence of this polymorphism has been surveyed among RA patients compared with healthy persons. The samples were selected from Isfahan province (one of the most populated area of Iran).
Materials and Methods: In this study, 100 patients (case group) and 100 healthy persons (control group) were participated voluntarily. The case group was selected from people who had referred to the rheumatology clinic of AlZahra University Hospital to follow-up their treatment and change their drugs dosage. The control group members, who were living in Isfahan province, mutually had similar age with patients. On a total, 22% of the case group was male and 75% of the control group was female. DNA was extracted from the blood sample of all cases and controls and the PTPN22 single nucleotide polymorphism (SNP) C1858> T gene polymorphism were studied using the polymerase chain reaction-restriction fragment length polymorphism method.
Results: PTPN22 SNP C1858> T gene polymorphism was observed in 11 persons (11%) of the case group and 8 persons (8%) of the control group.
Conclusion: The results show that the difference was not statistically significant in Isfahan RA population (P = 0.47; OR = 1.42; 95% CI 0.55-3.69). Although, another study on Iranian population had shown that this polymorphism confers susceptibility to RA. |
topic |
Isfahan polymorphism protein tyrosine phosphates number 22 rheumatoid arthritis |
url |
http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=218;epage=218;aulast=Salesi |
work_keys_str_mv |
AT mansoursalesi assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients AT golshantaghipourboroujeni assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients AT mansoorsalehi assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients AT hadikarimzadeh assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients |
_version_ |
1725679628440305664 |